Cost-effectiveness and cost-utility of combination therapy in early rheumatoid arthritis: randomized comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone

Authors
Category Primary study
Year 1998
This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Due to better efficacy and lower, or equal, direct cost, the combined treatment was argued to be more cost-effective than sulphasalazine alone.
Epistemonikos ID: 6dcc8bb19fe42b87b68207dd0106cb80f59ea9fe
First added on: Apr 19, 2023